StonvexLoading…
StonvexStonvexStonvexCore line items from ROL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-21 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.11B | $906.42M | $3.76B | $2.85B | $1.82B |
Operating Income | Not available | $145.49M | $726.07M | $566.00M | $340.98M |
Net Income | Not available | $107.84M | $526.71M | $410.26M | $246.74M |
EPS (Diluted) | $0.35 | $0.22 | $1.09 | $0.85 | $0.51 |
Total Assets | Not available | $3.16B | $3.14B | $3.22B | $3.18B |
Total Liabilities | Not available | $1.78B | $1.77B | $1.69B | $1.74B |
Cash & Equivalents | Not available | $116.54M | $100.00M | $127.36M | $123.03M |
Free Cash Flow OCF − CapEx | Not available | $111.23M | $650.02M | $491.00M | $308.16M |
Shares Outstanding | Not available | 481.46M | 481.19M | 484.63M | 484.64M |